| Brita Marie Angelone, ARNP | |
|
1200 E Pecan St, Altus, OK 73521-6141 | |
| (580) 379-5690 | |
| Not Available |
| Full Name | Brita Marie Angelone |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1200 E Pecan St, Altus, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124329305 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP 60189621 (Washington) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 117962 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brita Marie Angelone, ARNP 1200 E Pecan St, Altus, OK 73521-6141 Ph: (580) 379-5690 | Brita Marie Angelone, ARNP 1200 E Pecan St, Altus, OK 73521-6141 Ph: (580) 379-5690 |
News Archive
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, announced today that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and selecting clones relating to the basic UNIclone® technology and is already granted in Europe with the publication number EP1073770 B1.
MorphoSys AG's (FSE: MOR; Prime Standard Segment, TecDAX) partner OncoMed Pharmaceuticals today announced that Proceedings of the National Academy of Sciences of the United States of America (PNAS) has published online data demonstrating the potent anti-cancer activity of OMP-18R5, a HuCAL antibody targeting the Wnt pathway, in multiple preclinical human tumor models. OMP-18R5 is currently in Phase 1 clinical testing.
More than 80 percent of hepatitis C patients in each arm of the Phase 2 Study C208 achieved a sustained viral response (SVR) with a telaprevir-based regimen according to results of an intent-to-treat (ITT) analysis announced today by Vertex Pharmaceuticals Incorporated.
The prevalence of allergic diseases has increased significantly over the last decades, creating substantial financial and societal burdens. Due to this, researchers are trying to discover new approaches to the prevention and treatment of these diseases.
Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.
› Verified 6 days ago
Jonie Gene Lyon, APRN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 416 N Main St, Altus, OK 73521 Phone: 580-379-0925 | |
Alexis Bielski, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 S Park Ln Ste 100, Altus, OK 73521 Phone: 580-379-6100 Fax: 580-379-6109 | |
Tiffany J Forster, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3000 N Main St Ste A, Altus, OK 73521 Phone: 580-563-0454 Fax: 580-603-8602 | |
Jana Finch, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 401 W Tamarack Rd, Altus, OK 73521 Phone: 609-495-4115 | |
Mrs. Cherity Dawn Burrows, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 916 N Main St, Altus, OK 73521 Phone: 580-480-0033 | |
Mrs. Kristi Nicole Fry, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 205 S Park Ln, Altus, OK 73521 Phone: 580-379-6650 Fax: 580-379-6659 |